Clinical Effectiveness of a Combination of Black Elder Berries, Violet Herb, and Calendula Flowers in Chronic Obstructive Pulmonary Disease: The Results of a Double-Blinded Placebo-Controlled Study
Authors:
- Tatiana V. KirichenkoTKTatiana V. Kirichenko
- Igor A. SobeninISIgor A. Sobenin
- Yuliya V. MarkinaYMYuliya V. Markina
- Elena V. GerasimovaEGElena V. Gerasimova
- Andrey V. GrechkoAGAndrey V. Grechko
- Dmitry A. KashirskikhDKDmitry A. Kashirskikh
- Elena B. RomanenkoERElena B. Romanenko
- Wei-Kai WuWWWei-Kai Wu
- Alexander N. OrekhovAlexander N. Orekhov
Open Access
Abstract
Chronic obstructive pulmonary disease (COPD) is a multifactorial disease, in which systemic inflammation plays a key role. This 6-month randomized double-blinded placebo-controlled study evaluates the possible effect of natural preparation Inflaminat on clinical symptoms of COPD, indicators of respiratory function, and exacerbation frequency in 60 patients with moderate severity of COPD. Inflaminat is a combination of natural ingredients black elder (Sambucus nigra L.) berries, violet (Viola tricolor L.) herb, and calendula (Calendula officinalis L.) flowers. The preparation has been previously demonstrated to possess anticytokine and anti-inflammatory effects in experimental studies. In present study, COPD dynamics were evaluated by means of BCSS (Breathlessness, Cough, and Sputum Scale) and spirometry tests. It was shown that 6-months Inflaminat administration led to significant decrease of BCSS points from 3.0 ± 0.6 to 1.9 ± 0.7, (p = 0.002) as well as significant increase of FEV1 from 66 ± 18% to 73 ± 17%, (p = 0.042); there were no beneficial dynamics in placebo group. Side effects associated with preparation administration were not identified. The results of the study suggest that Inflaminat may be employed in treatment of patients with moderate severity of COPD, since it has a positive effect on COPD symptoms according BCSS and indicators of respiratory function FEV1.Keywords
Funding Information
- Russian Science Foundation (Grant #18-15-00254)
This publication has 28 references indexed in Scilit:
- Anti-cytokine therapy for prevention of atherosclerosisPhytomedicine, 2016
- Biomarkers in Coronary Artery Bypass Surgery: Ready for Prime Time and Outcome Prediction?Frontiers in Cardiovascular Medicine, 2016
- Phytoestrogen-Rich Dietary Supplements in Anti-Atherosclerotic Therapy in Postmenopausal WomenCurrent Pharmaceutical Design, 2015
- Effects of Two Chinese Herbal Formulae for the Treatment of Moderate to Severe Stable Chronic Obstructive Pulmonary Disease: A Multicenter, Double-Blind, Randomized Controlled TrialPLOS ONE, 2014
- Chronic obstructive pulmonary disease: patho-physiology, current methods of treatment and the potential for simvastatin in disease managementExpert Opinion on Drug Delivery, 2011
- The Cytokine Network in Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory Cell and Molecular Biology, 2009
- T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patientsClinical and Experimental Immunology, 2009
- The Safety and Efficacy of Infliximab in Moderate to Severe Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2007
- Evaluating symptoms in chronic obstructive pulmonary disease: validation of the breathlessness, cough and sputum scale©Respiratory Medicine, 2003
- Granulocyte Inflammatory Markers and Airway Infection during Acute Exacerbation of Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2001